Registry for Upper Gastrointestinal Bleeding

Study Overview
=================
Brief Summary
-----------------
This project aims to evaluate the data on all patients undergoing endoscopic therapy for upper gastrointestinal bleeding.

Detailed Description
-----------------
This project is being performed to evaluate the outcomes of patients undergoing endoscopic procedures for upper gastrointestinal bleeding at all AdventHealth hospitals in Central Florida. This information will enable quality control of patients undergoing treatment for upper gastrointestinal bleeding across all campuses in the AdventHealth system in Central Florida and hence improve the delivery ot care extended to the investigator's patients.

Official Title
-----------------
The Orange County Bleeding Consortium (OCBC): Registry of Patients Undergoing Endoscopic Procedures for Upper Gastrointestinal Bleeding in AdventHealth Hospitals in Central Florida

Conditions
-----------------
Peptic Ulcer Hemorrhage, Peptic Ulcer, Acute With Hemorrhage

Intervention / Treatment
-----------------
* Procedure: Upper GI Endoscopy


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patient is 18 years of age or greater Patient is undergoing endoscopic treatment for upper gastrointestinal bleeding Exclusion Criteria: Under the age of 18 Patient not undergoing endoscopic treatment for upper gastrointestinal bleeding

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients with upper gastrointestinal bleeding<br>Patients with upper gastrointestinal bleeding undergoing endoscopic procedures at AdventHealth Hospitals in Central Florida | Procedure: Upper GI Endoscopy<br>* Patients with upper gastrointestinal bleeding undergoing endoscopic therapy. Information regarding the need for interventional radiology procedures or surgical interventions will also be collected in patients in whom endoscopic therapy is not successful.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Mortality Rate | Mortality rate from upper gastrointestinal bleeding and from any etiology | 30 days | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Rate of Reintervention | Need for repeat endoscopic treatment for upper gastrointestinal bleeding | 30 days | 
| Rate of Recurrence | Recurrence of upper gastrointestinal bleeding following endoscopic treatment | 30 days | 
| Rate of Readmission | Need for readmission to hospital for treatment of upper gastrointestinal bleeding | 30 days | 
| Length of hospital stay | Length of hospitalization from index endoscopic procedure to discharge | 30 days | 
| Costs | Total hospital costs from admission for upper gastrointestinal bleeding | 30 days | 
| Treatment success | Successful treatment of upper gastrointestinal bleeding using endoscopic therapy as determined by a yes/no answer. | 30 days |